MAX BioPharma and Revilico Collaboration LOS ANGELES, CA / ACCESS Newswire / August 6, 2025 / Today MAX BioPharma, Inc. ( and Revilico, Inc. ( announced their collaboration in studying the mechanisms ...

Mission Bio, a leader in single-cell multi-omics solutions for precision medicine, today announced the successful completion of equity financing led by Ally Bridge Group. The investment will fund new ...

The review explores how AI and omics technologies are revolutionizing biobanking for public health, enabling precision ...

Published in Frontiers in Science, the map of 'agri-food system microbiomes' reveals how players at every stage of the food ...

About one quarter of patients with muscle-invasive bladder cancer (MIBC) may be treated and derive a benefit with the current ...

Scientists from the Qingdao Institute of Bioenergy and Bioprocess Technology (QIBEBT) of the Chinese Academy of Sciences have ...

Drug repurposing - identifying new uses for existing medications- has emerged as a transformative approach in oncology, offering a cost-effective and ...

Researchers have mapped how microbes underpin our food systems—and how we can stop their decline. Published in Frontiers in ...

The tumor microenvironment (TME) is a complex and dynamic ecosystem crucial for cancer progression and therapeutic response. Tumors actively shape this ...

Colorectal cancer is among the most prevalent and lethal malignancies worldwide, with liver metastases occurring in nearly ...

Panome Bio, a leader in advanced proteomic, metabolomic and transcriptional profiling technologies, announced it has achieved Clinical Laboratory Improvement Amendments (CLIA) certification for ...